Provided by Tiger Fintech (Singapore) Pte. Ltd.

HBM HOLDINGS-B

7.470
+0.70010.34%
Volume:13.67M
Turnover:100.92M
Market Cap:5.65B
PE:30.96
High:7.620
Open:6.900
Low:6.900
Close:6.770
Loading ...

BRIEF-HBM Holdings Says NMPA Ind Clearance For Hbm9378/Skb378

Reuters
·
05 Feb

Hbm Holdings - Nmpa Ind Clearance for Hbm9378/Skb378 in Treatment of Copd

THOMSON REUTERS
·
05 Feb

HBM's CEO Boosts Stakeholding

MT Newswires Live
·
03 Feb

BRIEF-HBM Says CEO & Chairman Purchased Total 400,000 Ordinary Shares Of Co

Reuters
·
28 Jan

Hbm - CEO & Chairman Purchased Total 400,000 Ordinary Shares of Co on 27 Jan for HK$3.5 per Share

THOMSON REUTERS
·
28 Jan

HBM, SKB Biopharma Sign License Agreement for Anti-Asthma, COPD Drug

MT Newswires Live
·
13 Jan

BRIEF-HBM Holdings Announces License Agreement With Windward Bio AG

Reuters
·
10 Jan

BRIEF-Windward Bio Launches With $200 Million Series A Financing

Reuters
·
10 Jan

Windward Bio Launches With $200 Million Series a Financing to Develop Phase 2-Ready, Long-Acting Anti-Tslp Antibody With Best-in-Class Potential in Asthma and Copd

THOMSON REUTERS
·
10 Jan

BRIEF-Harbour Biomed Signs License Agreement With Windward Bio For HBM9378

Reuters
·
10 Jan

Harbour Biomed Announces License Agreement With Windward Bio for Hbm9378/Skb378, an Anti-Tslp Fully Human Antibody for Immunological Diseases

THOMSON REUTERS
·
10 Jan

Hbm Holdings: $45 Mln Upfront & Near-Term Milestone Payments Include Both Cash Payment & Equity Interest in Windward Bio's Parent Company

THOMSON REUTERS
·
10 Jan

Hbm Holdings Ltd - Harbour Biomed and Kelun-Biotech Eligible for up to $970 Million Upfront and Milestone Payments

THOMSON REUTERS
·
10 Jan

Hbm Holdings - Entering Into License Agreement With Windward Bio Ag

THOMSON REUTERS
·
10 Jan

Hbm Holdings - License Agreement Excludes Greater China and Several Southeast and West Asian Countries

THOMSON REUTERS
·
10 Jan

HBM to Repurchase Shares for Up to HK$40 Million; Shares Rise 8%

MT Newswires Live
·
02 Jan